Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (3) : immunotherapy

SU2C Expands Scientific Advisory Committee with New Cancer Research Leaders

SU2C Expands Scientific Advisory Committee with New Cancer Research Leaders
08/03/2026 | Companies
Stand Up To Cancer (SU2C) has expanded its Scientific Advisory Committee with the appointment of several new members. The 30-member committee, led by a chair and supported by two vice-chairs, plays a central role in shaping the organization's research funding priorities and providing guidance...
Adrian Bot, Arnold Levine, artificial intelligence, biomedical innovation, cancer funding, cancer genomics, cancer research, cancer scientists, Christina Curtis, City of Hope Cancer Center, healthcare, immunotherapy, John Carpten, Johns Hopkins, Julian Adams, Lisa Butterfield, Martin Pomper, medical research, oncology, research leadership, scientific advisors, Scientific Advisory Committee, Shawna Hudson, Srikant Ramaswami, Stand Up To Cancer, Stanford Cancer Institute, SU2C, Trevor Pugh, Trey Ideker, William G. Nelson

Mabwell Advances 6MW5311 Bispecific Antibody for AML and Blood Cancers

Mabwell Advances 6MW5311 Bispecific Antibody for AML and Blood Cancers
04/16/2026 | Companies
Mabwell (688062.SH), an innovation-focused biopharmaceutical company with an integrated value chain, has announced that the National Medical Products Administration (NMPA) has accepted the Investigational New Drug (IND) application for its novel LILRB4/CD3 T cell engager (TCE) bispecific antibody,...
6MW5311, acute myeloid leukemia, AML, biopharmaceuticals, biotechnology, bispecific antibody, cancer research, CD3, chronic myelomonocytic leukemia, clinical trials, CMML, cytotoxicity, drug development, FDA, hematologic malignancies, immune synapse, immunotherapy, IND application, LILRB4, Mabwell, MM, multiple myeloma, NMPA, oncology, preclinical studies, stem cell transplantation, steric hindrance, T cell engager, targeted therapy, TCE technology, tumor inhibition

Join Team ScottsMiracle-Gro in Pelotonia: Support Cancer Research Through Cycling

Join Team ScottsMiracle-Gro in Pelotonia: Support Cancer Research Through Cycling
09/26/2024 | Companies
Pelotonia is just around the corner, and Team ScottsMiracle-Gro is gearing up to cycle between 20 and 190 miles across central Ohio. This initiative focuses on teamwork among associates to support cancer research. Our involvement with Pelotonia dates back to 2010, and we often receive a few common...
associate teamwork, awareness, brain tumors, breast cancer, cancer research, commitment, community ride, cycling, fundraising, fundraising deadline, healthcare, immunotherapy, impact, lung cancer, OSUCCC, Pelotonia, ride weekend, ScottsMiracle-Gro, support, targeted therapy, The James, training


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com